Home Newsfeeds BTIG Downgrades Taysha Gene Therapies to Neutral

BTIG Downgrades Taysha Gene Therapies to Neutral

BTIG analyst Yun Zhong downgrades Taysha Gene Therapies (NASDAQ:TSHA) from Buy to Neutral.

byBenzinga Newsdesk

February 2, 2023

1 minute read

BTIG analyst Yun Zhong downgrades Taysha Gene Therapies (NASDAQ:TSHA) from Buy to Neutral.

Raymond James Downgrades Hilltop Holdings to Underperform

By Benzinga Newsdesk

July 7, 7:34 AM

Raymond James analyst Michael Rose downgrades Hilltop Holdings (NYSE:HTH) from Market Perform to Underperform.

HTH

Nasdaq, S&P 500 Futures Wobble On Inflation Data Anxiety: Why This Analyst Isn’t Sweating Over A Hot Print

By Shanthi Rexaline

September 13, 6:41 AM

U.S. stock futures flatlined with a negative bias ahead of the August inflation data, which could have a say on next week's Fed decision.

AAPL

Elon Musk Wasn’t Joking! Boring Company Is Really Bringing You ‘Burnt Hair’ Cologne

By Benzinga Overnight Desk

October 9, 11:34 PM

Elon Musk on Sunday posted a picture of a cologne bottle with the fragrance "burnt hair" on Twitter, saying the product would soon be brought to the market by The Boring Company. The Boring Company is a tunnel construction services company founded by Musk in 2016.

TSLA

Why Super Group Shares Are Trading Higher Today

By Nabaparna Bhattacharya

August 17, 10:55 AM

Super Group (SGHC) Limited (NYSE: SGHC) reported the second quarter of FY23 revenues of $415.034 million,

SGHC

BTIG Downgrades Taysha Gene Therapies to Neutral

Related Posts

Raymond James Downgrades Hilltop Holdings to Underperform

Nasdaq, S&P 500 Futures Wobble On Inflation Data Anxiety: Why This Analyst Isn’t Sweating Over A Hot Print

Elon Musk Wasn’t Joking! Boring Company Is Really Bringing You ‘Burnt Hair’ Cologne

Why Super Group Shares Are Trading Higher Today